PLoS ONE (Jan 2017)

Human plasma-derived C1 esterase inhibitor concentrate has limited effect on house dust mite-induced allergic lung inflammation in mice.

  • Ingrid Stroo,
  • Jack Yang,
  • Adam A Anas,
  • J Daan de Boer,
  • Gerard van Mierlo,
  • Dorina Roem,
  • Diana Wouters,
  • Ruchira Engel,
  • Joris J T H Roelofs,
  • Cornelis van 't Veer,
  • Tom van der Poll,
  • Sacha Zeerleder

DOI
https://doi.org/10.1371/journal.pone.0186652
Journal volume & issue
Vol. 12, no. 10
p. e0186652

Abstract

Read online

C1 esterase inhibitor (C1-INH) can inhibit multiple pathways (complement, contact-kinin, coagulation, and fibrinolysis) that are all implicated in the pathophysiology of asthma. We explored the effect of human plasma-derived C1-INH on allergic lung inflammation in a house dust mite (HDM) induced asthma mouse model by daily administration of C1-INH (15 U) during the challenge phase. NaCl and HDM exposed mice had comparable plasma C1-INH levels, while bronchoalveolar lavage fluid (BALF) levels were increased in HDM exposed mice coinciding with slightly reduced activation of complement (C5a). C1-INH treatment reduced Th2 response and enhanced HDM-specific IgG1. Influx of eosinophils in BALF or lung, pulmonary damage, mucus production, procoagulant response or plasma leakage in BALF was similar in both groups. In conclusion, C1-INH dampens Th2 responses during HDM induced allergic lung inflammation.